Central retinal vein occlusion and thrombophilia

被引：0
作者：
C D Fegan
机构：
[1] Birmingham Heartlands Hospital,Department of Haematology
来源：
Eye | 2002年 / 16卷
关键词：
central retinal vein occlusion; thrombophilia; factor V Leiden; hyperhomocysteinaemia; antiphospholipid syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Central retinal vein occlusion is one of the commonest vascular diseases of the eye. The pathogenesis is multifactorial with both local factors and systemic diseases being aetiologically important. Many thrombophilic conditions have recently been identified and studies looking at their potential role in CRVO have been undertaken. The aim of this review is to critically appraise these studies as to date many have given conflicting results, making it far from clear what role thrombophilic conditions play in CRVO. It appears that hyperhomocysteinaemia and antiphospholipid syndrome are causes of CRVO and there is evidence that disorders causing hypofibrinolysis may also be important. The common hereditary thrombophilic conditions however do not appear to be strong risk factors but larger studies are needed for a definitive answer.
引用
收藏
页码：98 / 106
页数：8
相关论文
共 305 条
  • [1] Dahlback B(1993)Familial thrombophilia due to a previously unrecognised mechanism characterised by a poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C Proc Natl Acad Sci USA 90 1004-1008
  • [2] Carlsson M(1994)Mutation in the blood coagulation factor V associated with resistance to activated protein C Nature 360 64-67
  • [3] Svensson PJ(1994)Activated protein C as an additional risk factor for thrombosis in protein C deficient families Blood 84 1031-1035
  • [4] Bertina RM(1995)Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemostat 74 580-583
  • [5] Koeleman BPC(1994)Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1453-1457
  • [6] Koster T(1996)Risk of hospital admission for ideopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 348 981-983
  • [7] Rosendaal FR(1996)Risk of venous thromboembolism in users of hormone replacement therapy Lancet 348 977-980
  • [8] Dirven RJ(1995)Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraception Am J Obstet Gynaecol 173 210-213
  • [9] De Ronde H(1994)Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics Am J Ophthalmol 117 429-441
  • [10] Koeleman BPC(1996)Prevalence and associations of retinal vein occlusion in Australia. The Blue Eye Mountain Study Arch Ophthalmol 114 1243-1247
12345678910